Russell Investments Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-190,471
| Closed | -$1.79M | – | 3291 |
|
|
2020
Q3 | $1.79M | Sell |
190,471
-11,347
| -6% | -$108K | ﹤0.01% | 1752 |
|
|
2020
Q2 | $1.54M | Hold |
201,818
| – | – | ﹤0.01% | 1793 |
|
|
2020
Q1 | $1.25M | Buy |
201,818
+31,751
| +19% | +$280K | ﹤0.01% | 1739 |
|
|
2019
Q4 | $2.07M | Buy |
170,067
+68,367
| +67% | +$747K | ﹤0.01% | 1719 |
|
|
2019
Q3 | $1.18M | Buy |
101,700
+10,900
| +12% | +$115K | ﹤0.01% | 1935 |
|
|
2019
Q2 | $907K | Buy |
90,800
+43,600
| +92% | +$470K | ﹤0.01% | 2025 |
|
|
2019
Q1 | $608K | Buy |
47,200
+24,400
| +107% | +$363K | ﹤0.01% | 2277 |
|
|
2018
Q4 | $347K | Sell |
22,800
-513,409
| -96% | -$9.78M | ﹤0.01% | 2439 |
|
|
2018
Q3 | $10.7M | Sell |
536,209
-634,123
| -54% | -$14.4M | 0.02% | 898 |
|
|
2018
Q2 | $22.9M | Buy |
1,170,332
+415,741
| +55% | +$9.2M | 0.05% | 481 |
|
|
2018
Q1 | $15.2M | Buy |
754,591
+148,113
| +24% | +$2.51M | 0.03% | 753 |
|
|
2017
Q4 | $8.16M | Sell |
606,478
-38,704
| -6% | -$584K | 0.01% | 1086 |
|
|
2017
Q3 | $11.9M | Buy |
645,182
+80,217
| +14% | +$1.5M | 0.02% | 859 |
|
|
2017
Q2 | $10.4M | Sell |
564,965
-10,699
| -2% | -$212K | 0.02% | 903 |
|
|
2017
Q1 | $13M | Buy |
575,664
+223,092
| +63% | +$5.34M | 0.02% | 740 |
|
|
2016
Q4 | $12.4M | Buy |
+352,572
| New | +$10.5M | 0.02% | 749 |
|
Russell Investments Group's AMAG Position: Q4 2020 in Review
Russell Investments Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 190,471 shares — an estimated $1.79M sold.
Russell Investments Group first reported a position in AMAG in Q4 2016 and held it in 16 quarters. The position peaked at $22.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Russell Investments Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Russell Investments Group sold 190,471 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.79M.
- Russell Investments Group first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 16 quarters.
- Russell Investments Group's AMAG Pharmaceuticals position peaked at $22.9M in Q2 2018.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.